Cita APA

de Oyarzabal, E., García-García, L., Rangel-Escareño, C., Ferreyra-Reyes, L., Orozco, L., Herrera, M. T., . . . Torres, M. (2019). Expression of USP18 and IL2RA Is Increased in Individuals Receiving Latent Tuberculosis Treatment with Isoniazid. J Immunol Res.

Chicago Style Citation

de Oyarzabal, Eleane, et al. "Expression of USP18 and IL2RA Is Increased in Individuals Receiving Latent Tuberculosis Treatment With Isoniazid." J Immunol Res 2019.

Cita MLA

de Oyarzabal, Eleane, et al. "Expression of USP18 and IL2RA Is Increased in Individuals Receiving Latent Tuberculosis Treatment With Isoniazid." J Immunol Res 2019.